Clinical Trial Update: Trial of NovoSeven® in Haemophilia - Joint Bleeds [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for NovoSeven in haemophilia patients with inhibitors; the study on joint bleeds has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Bleeding Disorder
• Haemophilia with Inhibitors

Drugs mentioned

• NovoSeven (recombinant coagulation factor VIIa)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Haemophilia A With Inhibitors | Phase 4 | Status: COMPLETED